All News

TheDaoIndex Tweet
KDAO2011
Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: Treatment algorithms for GIO and in special populations (age < 18) @rheumnow https://t.co/dZ02kuOUeH
David Liew Tweet
drdavidliew
Of course, imaging itself can be useful in PMR in many situations - and, like GCA, there are merits to all of ultrasound, MRI, and PET/CT. Nice summary slide @drceowen #ACR22 @RheumNow https://t.co/1LO3DvW7tm
Eric Dein Tweet
ericdeinmd
14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 🦴🦴 Special pops recs for: Organ transplant - against romosozumab (CVD risk) Women of child bearing age (not planning) - BIS/TERI Children - Vit D/Ca unless Fx Very high doses: more aggressive @RheumNow https://t.co/xY7Yc3BANj
Julian Segan Tweet
JulianSegan
Paul Emery presenting phase 2 data Peresolimab in RA. Novel mechanism aiming to restore immune homeostasis. Exciting for rheumatic disease beyond RA. @RheumNow #ACR22 #LateBreaking https://t.co/oOjvo5YmDB
Catherine Sims, MD Tweet
DrCassySims
Reproductive concerns of adolescent patients with rheumatic disease Abstract #129 #ACR22 @RheumNow 🤰Worried about effects of dx and meds on fertility and pregnancy 💊Concerns about which birth control to use 🩸Effects of dx. on menstruation
Olga Petryna Tweet
DrPetryna
#L02 #acr22 @rheumnow Bimekizumab ph3 in PsA: meaningful clinical improvement, improved mTSS, no new safety signals. Wk 52 ACR50: 53.0% PBO/BKZ, 54.5% BKZ, 50.0% ADA; MDA 53.7% PBO/BKZ, 55.0% BKZ, 52.9% ADA . mTSS change from baseline ≤0.5): 87.3% PBO/BKZ, 89.3% BKZ, 94.1% ADA https://t.co/NYRrPUBjt1
David Liew Tweet
drdavidliew
Ultrasound and MRI have taught us a lot about PMR, but it's the power of PET/CT which illustrated the specific pathology of PMR in full color vision. @drceowen #ACR22 @RheumNow https://t.co/N8hVjqpVwe
Eric Dein Tweet
ericdeinmd
14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 🦴🦴 Initial Fracture Risk Assessment - by age - remember: no FRAX scores <40 yo Fracture re-assessments every 1-2 years with repeat BMD and risk stratifications @RheumNow https://t.co/QlCVM1lDb0
TheDaoIndex Tweet
KDAO2011
Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: in patients under 40 yo, you cannot calculate #FRAX score, assess BMD and in children get also thoracolumbar xrays. Get repeat testing every 1-2 years #ACR22 @rheumnow https://t.co/CgsvzGKYuV
Janet Pope Tweet
Janetbirdope
Get the skinny on Bimmy! Gotta learn this name #Bimekizumab in bio naive PsA N=852 Bimmy=IL17 A & F inhibitor Great data on skin & joints. Where will it fit in as we have other IL17Ai’s is IL17F giving added value? #ACR22 #ACRBest @RheumNow https://t.co/wNAzTaLhsM
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×